-
Gilead Sciences Announces First Quarter 2024 Financial Results
25 Apr 2024 20:12 GMT
… the accompanying tables.
About Gilead Sciences
Gilead Sciences, Inc. is a … Gilead’s ability to achieve its anticipated full year 2024 financial results … business, including the following: GILEAD®, GILEAD SCIENCES®, KITETM, AMBISOME®, ATRIPLA®, …
-
Merck Announces First-Quarter 2024 Financial Results
25 Apr 2024 10:54 GMT
… States and Canada, today announced financial results for the first quarter of … transcriptase translocation inhibitor (NRTTI), and Gilead Sciences, Inc.’s lenacapavir, a first … Announcement)
Infectious Diseases
Merck and Gilead Announced Phase 2 Data Showing …
-
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
23 Apr 2024 12:55 GMT
… will report first quarter 2024 financial results after the close of the … that same day to discuss financial results and provide a general business … Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences and Baxter International. For more …
-
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
23 Apr 2024 12:50 GMT
… will report first quarter 2024 financial results after the close of the … that same day to discuss financial results and provide a general business … Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences and Baxter International. For more …
-
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
19 Apr 2024 12:15 GMT
… report its first quarter 2024 financial results on Thursday, May 9, 2024 … , Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development …
-
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
10 Apr 2024 11:00 GMT
… the Strategic Collaboration with Gilead Sciences
Extended the Strategic Collaboration … inflammatory diseases, today reported financial results for the first quarter ended … programs.” Recent Business Highlights
Gilead Sciences elected to extend the research …
-
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
08 Apr 2024 20:18 GMT
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2024 financial results … company’s first quarter 2024 financial results and provide a business … there for one year.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical …
-
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
01 Apr 2024 20:05 GMT
… business updates and reported financial results for the fourth quarter … 2024, Xilio and Gilead Sciences, Inc. (Gilead) announced an exclusive … package for XTX301, Gilead can elect to transition … exclusive license agreement with Gilead Sciences, Inc. for Xilio …
-
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
28 Mar 2024 20:05 GMT
… 1b data available in 1H2025
Gilead Sciences, Inc. partnership supports advancement … serious viral diseases, today reported financial results and recent highlights for the … benefits of its collaboration with Gilead Sciences, Inc., including all financial …
-
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023
28 Mar 2024 00:03 GMT
… , today announced its financial results for the full year … a wholly-owned subsidiary of Gilead Sciences, Inc., for Trodelvy® … the transition period with Gilead in Singapore.
Our general … 47;everest-medicines-announces-financial-results-for-full-year-ended- …